Abstract
Three different batches of pure nanoparticles (NPs) of nicergoline (NIC) were prepared by spray drying a water:ethanol solution by a new Nano Spray Dryer Büchi B-90. Spherical pure NPs were obtained, and several analytical techniques such as differential scanning calorimetry and X-ray powder diffractometry permitted to assess their amorphous character. A comparison of the solubility, intrinsic dissolution, and drug release of original particles and pure amorphous NPs were determined, revealing an interesting improvement of biopharmaceutical properties of amorphous NPs, due to both amorphous properties and nanosize dimensions. Since in a previous work, the high-thermodynamic stability of amorphous NIC was demonstrated, this study is addressed toward the formulation of NIC as pure amorphous NPs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahlneck C, Zografi G (1990) The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 62:87–95
Andronis V, Yoshioka M, Zografi G (1997) Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J Pharm Sci 86:346–351
Banakar UV (1992) In: Swarbrick J (ed) Pharmaceutical dissolution testing. Marcel Dekker, New York, pp 55–105
Brossi A (1990) The alkaloids. Chemistry and pharmacology, 38. Academic Press Inc, San Diego, p 142
Crowley KJ, Zografi G (2002) Water vapour absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J Pharm Sci 90:2150–2165
Elversson J, Millqvist-Fureby A, Alderborn G, Eloffson U (2003) Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J Pharm Sci 92:900–910
Gao L, Zhang D, Chen M (2008) Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res 10:845–862
Goo D, Palosi E, Szporny L (1988) Comparison of the effects of vinpocetine, vincamine, and nicergoline on the normal and hypoxia-damaged learning process in spontaneously hypertensive rats. Drug Dev Res 15:75–85
Hamaura T, Newton JM (1999) Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol. J Pharm Sci 88:1228–1232
Hancock BC, Parks M (2000) What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17:397–403
Heitz C, Descombes JJ, Miller RC, Stoclet JC (1986) α-Adrenoceptor antagonistic and calcium antagonistic effects of nicergoline in the rat isolated aorta. Eur J Pharmacol 123:279–285
ICH Topic Q 1 A (R2) (2003) Stability testing of new drug substances and products. Note for guidance on stability testing: stability testing of new drug substances and products. (CPMP/ICH/2736/99). EMEA, London, pp 1–20
Junghanns JAH, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3:295–309
Kontny MJ, Zografi G (1995) Sorption of water by solids. In: Brittain HG (ed) Physical characterization of pharmaceutical solids. Marcel Dekker, New York, pp 387–418
Maa YF, Nguyen PA, Sweeney T, Shire SJ, Hsu CC (1999) Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res 16:249–254
Malaj L, Censi R, Capsoni D, Pellegrino L, Bini M, Ferrari S, Gobetto R, Massarotti V, Di Martino P (2011) Characterization of nicergoline polymorphs crystallized in several organic solvents. J Pharm Sci 100:2610–2622
Martena V, Censi R, Hoti E, Malaj L, Di Martino P (2011) Physicochemical characterization of nicergoline and cabergoline in its amorphous state. J Therm Anal Calorim doi: 10.1007/s10973-011-1954-2
Mauludin R, Müller RH, Keck CM (2009) Development of an oral rutin nanocrystal formulation. Int J Pharm 370:202–209
Merisko-Liversidge E (2002) Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds. In: Marty JJ (Ed) Particles. Marcel Dekker, Orlando
Noyes A, Whitney WR (1897) The rate of solution of solid substances in their own solutions. J Am Chem Soc 19:930–934
Pastoris O, Vercesi L, Allorio F, Dossena M (1988) Effect of hypoxia, aging and pharmacological treatment on muscular metabolites and enzyme activities. Il Farmaco Ed Sci 43:627–642
Schmitt E, Davis CW, Long ST (1996) Moisture-dependent crystallization of amorphous lamotrigine mesylate. J Pharm Sci 85:1215–1219
Shamblin SL, Zografi G (1999) The effects of absorbed water on the properties of amorphous mixtures containing sucrose. Pharm Res 16:1119–1124
Shegokar R, Müller RH (2010) Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 399:129–139
Speiser PP (1998) Poorly soluble drugs: a challenge in drug delivery. In: Benita S, Böhm B, Müller RH (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 15–28
Taylor LS, Shamblin SL (2009) Amorphous solids. In: Brittain HG (ed) Polymorphism. Informa Healthcare, New York, pp 594–596
Triulzi E, Devizzi S, Margonato A (1981) Use of nicergoline in acute myocardial infarction with diastolic hypertension. Il Farmaco (ed Prat) 36:449–455
Venn RD (1980) Review of clinical studies with ergots in gerontology. In: Goldstein M, Liberman A, Calne DB, Thorner MO (eds) Ergot compounds and brain function. Raven Press, New York, pp 363–377
Zografi G (1988) States of water associated with solids. Drug Dev Ind Pharm 14:1905–1926
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martena, V., Censi, R., Hoti, E. et al. A new nanospray drying method for the preparation of nicergoline pure nanoparticles. J Nanopart Res 14, 934 (2012). https://doi.org/10.1007/s11051-012-0934-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-012-0934-1